Heflich Rh Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
unknown
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Heflich Rh's research focuses on the assessment of carcinogenic outcomes associated with short-term exposure to DNA-reactive drugs. This work investigates the sufficiency of available data for informing risk assessment, particularly in the context of human health. Rh has published five papers, accumulating 55 citations and an h-index of 3. Key collaborators include Dayton M. Petibone and Jm Shemansky, both from the National Center for Toxicological Research, with whom Rh has co-authored one publication each. Rh's recent publication in 2025 indicates ongoing activity in this research area.
Metrics
- h-index: 3
- Publications: 5
- Citations: 55
Selected Publications
-
Assessing carcinogenic outcomes following short-term exposure to potentially DNA-reactive drugs: Are available data sufficient to inform risk assessment? (2025)
Collaboration Network
Top Collaborators
- Assessing carcinogenic outcomes following short-term exposure to potentially DNA-reactive drugs: Are available data sufficient to inform risk assessment?
- Assessing carcinogenic outcomes following short-term exposure to potentially DNA-reactive drugs: Are available data sufficient to inform risk assessment?
- Assessing carcinogenic outcomes following short-term exposure to potentially DNA-reactive drugs: Are available data sufficient to inform risk assessment?
- Assessing carcinogenic outcomes following short-term exposure to potentially DNA-reactive drugs: Are available data sufficient to inform risk assessment?
Similar Researchers
Based on overlapping research topics